Clinical Trials Logo

Vaginal Delivery clinical trials

View clinical trials related to Vaginal Delivery.

Filter by:

NCT ID: NCT06202768 Not yet recruiting - Vaginal Delivery Clinical Trials

Role of the Intrapartum Grobman Nomogram in the Indication of Attempted Vaginal Delivery After Cesarean Section

GPP
Start date: May 1, 2024
Phase:
Study type: Observational

The rate of pregnant patients with a history of cesarean section is increasing. Caesarean section is a surgery which is not without risk and in particular concerning the risk of uterine rupture and malplacentation during a new pregnancy. Considering the outcome of a new birth following a cesarean section is not easy. There is no reliable score to predict the success rate of vaginal delivery with a history of scarred uterus. The aim of our study would be to validate the intrapartum Grobman nomogram within the population of the Nancy University Hospital and thus to target the population for whom vaginal delivery could be offered.

NCT ID: NCT06126328 Completed - Clinical trials for Pelvic Organ Prolapse

Materna Prep Study Phase II

EASE
Start date: September 8, 2021
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery. Subjects are randomized to Materna Prep Device or Standard of Care without use of the Materna Prep Device Intervention with the Materna Prep Device is expected to be a one-time use of approximately 30-90 minutes during the 1st stage of labor. Subject participation in the study is targeted to be 3 months from the time of the use of the device during delivery with optional long-term follow-up.

NCT ID: NCT06044129 Not yet recruiting - Vaginal Delivery Clinical Trials

A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women

Start date: January 1, 2024
Phase:
Study type: Observational

The aim of this study was to use MRI imaging to accurately scan the pregnant woman's pelvis and fetal skull, build a 3D model of them, and combine with artificial intelligence to develop an accurate tool to predict the success rate of vaginal delivery.

NCT ID: NCT05786911 Completed - Vaginal Delivery Clinical Trials

Postpartum Fatigue and Pain Versus Nutritional Status, With Epidural Analgesia

Start date: October 27, 2022
Phase:
Study type: Observational

The objective of this preliminary observational study is to evaluate, in the patient, a correlation between a food habit and nutritional status score of the parturient and a postpartum fatigue (FSS) and pain (ENA) score on day 1, 3 and 7.

NCT ID: NCT05501106 Not yet recruiting - Clinical trials for Postpartum Hemorrhage

Reducing Postpartum Hemorrhage After Vaginal Delivery

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Postpartum hemorrhage is the primary cause threatening the life safety of pregnant women in the world and China, and also the main cause of hysterectomy for women giving birth. The management of postpartum hemorrhage necessitates a coordinated multidisciplinary approach but limited available data on this issue. This program aims to evaluate the effectiveness and acceptability of the integrated strategies, on postpartum hemorrhage after vaginal delivery and relevant clinical practice, in response to the increasing incidence of postpartum hemorrhage and its long-standing threaten to the life safety of pregnant women. A matched-pair, cluster-randomized controlled trial will be conducted among 50 maternity hospitals with at least 500 vaginal deliveries annually from five provinces in China. Recruited hospitals will be randomly assigned in a 1:1 ratio to either the experimental or comparison arms. All hospitals will receive general interventions, including: recommendation for implementing quality improvement programs to reduce vaginal delivery complications; trainings on obstetric quality management and clinical skills (3 times a year); and monitoring postpartum hemorrhage rate every month. The hospitals in the experimental group will additionally implement integrated improvement strategies which include postpartum hemorrhage risk screening, hierarchical management and preparedness, rescue recording, and case review. The primary outcome is the rate of postpartum hemorrhage, and the secondary outcomes include rate of consequent adverse outcomes, adherence to all known best practices, and staff acceptability to the interventions. These outcomes will be measured and compared between the experimental and control groups. Both intention-to-treat and per-protocol analyses will be performed.

NCT ID: NCT05429580 Completed - Clinical trials for Postpartum Hemorrhage

Prophylactic Tranexamic Acid Use After Vaginal Delivery

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

In this study, our aim was to evaluate the effectiveness of prophylactic tranexamic acid use after vaginal delivery in pregnant women aged 18-45 years and 34-42 weeks according to the risk of postpartum hemorrhage.

NCT ID: NCT05371015 Completed - Vaginal Delivery Clinical Trials

Quadratus Lumborum Block Reduced Postpartum Uterine Pain After Virginal Childbirth

Start date: May 12, 2022
Phase: N/A
Study type: Interventional

With the continuous advancement of ultrasonic technology, nerve block in which drugs are injected into the periphery of the target nerve through ultrasonic guidance has become the mainstream method for postoperative pain control. The quadratus lumborum nerve block has been effectively and safely used in abdominal surgery (such as laparotomy, caesarean section, etc.), effectively reducing postoperative wounds and visceral pain. There is no research on the use of quadratus lumborum nerve block to control the pain of natural postpartum uterine contractions in the current literature, so the purpose of this experiment is to explore whether the quadratus lumborum nerve block can effectively reduce the pain of uterine contractions after vaginal delivery.

NCT ID: NCT05247073 Not yet recruiting - Hematoma Clinical Trials

Mostafa Maged Four-stitch Technique in Closure the Episiotomy During Vaginal Delivery

Start date: March 2022
Phase: N/A
Study type: Interventional

Most primigravida is confronted with episiotomy during childbirth to prevent the perineal and vaginal lacerations which could be performed at birth. There are many types of episiotomy which are median, mediolateral, and J-shaped episiotomy. Prevention of the formation of the dead space during the repair of episiotomy so avoiding hematoma formation in the episiotomy area after child-birth. The Mostafa Maged four-stitch technique uses absorbable vicryl threads with round needles 75 mm.

NCT ID: NCT05143944 Not yet recruiting - Vaginal Delivery Clinical Trials

Audit of Management of First Stage of Labour in Assiut University Hospitals : a Quality Improvement Project

Start date: December 1, 2021
Phase:
Study type: Observational

auditing the current management of first stage of normal vaginal deliveries at Assiut university hospitals emergency obstetric care

NCT ID: NCT05122169 Not yet recruiting - Clinical trials for Surgical Site Infection

Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery

Start date: December 2021
Phase: N/A
Study type: Interventional

This is a multi-center, randomized, controlled trial study to find whether use of chlorhexidine-alcohol or povidone-iodine for pre-vaginal delivery skin prep is superior to reduce postpartum infection in pregnant women with vaginal delivery. The primary outcome is the episiotomy site infection.